CSS LLC’s Jazz Pharmaceuticals JAZZ Stock Holding History

CSS LLC’s Portfolio JAZZ Stock Details JAZZ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-2,000	Closed	-$340K	–	1088
2025 Q4	$340K	Buy	+2,000	New	+$307K	0.02%	653
2023 Q1	–	Sell	-5,952	Closed	-$948K	–	812
2022 Q4	$948K	Hold	5,952	–	–	0.05%	271
2022 Q3	$794K	Hold	5,952	–	–	0.04%	401
2022 Q2	$928K	Hold	5,952	–	–	0.04%	436
2022 Q1	$927K	Hold	5,952	–	–	0.03%	462
2021 Q4	$758K	Hold	5,952	–	–	0.03%	517
2021 Q3	$775K	Hold	5,952	–	–	0.03%	497
2021 Q2	$1.06M	Buy	+5,952	New	+$1.03M	0.04%	391

Other funds holding JAZZ

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

CSS LLC's JAZZ Position: Q3 2022 in Review

CSS LLC sold out of Jazz Pharmaceuticals (JAZZ) in Q3 2022, closing a stake of 1,600 shares — an estimated $243K sold.

CSS LLC first reported a position in JAZZ in Q2 2021 and held it in 5 quarters. The position peaked at $1.1M in Q1 2022. 468 funds tracked by Wall St. Rank hold JAZZ as of Q3 2022.

CSS LLC reported no remaining Jazz Pharmaceuticals position as of Q3 2022 after selling out during the quarter.
CSS LLC sold 1,600 Jazz Pharmaceuticals shares in Q3 2022, an estimated $243K.
CSS LLC first reported a position in Jazz Pharmaceuticals in Q2 2021 and held it in 5 quarters.
CSS LLC's Jazz Pharmaceuticals position peaked at $1.1M in Q1 2022.
468 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q3 2022.

Based on CSS LLC's 13F filing for Q3 2022, filed 14 Nov 2022.